National Institutes of Health: Gaucher Disease trials
The registry lists 12 Gaucher Disease studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 1 3Phase 2 3No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Genetic Studies of Lysosomal Storage DisordersEnrolling by invitationNCT00001215
- Clinical and Pathophysiological Investigations Into Erdheim Chester DiseaseCompletedNCT01417520
- A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher DiseaseCompletedNCT00465062
- Positron Emission Tomography (PET) Imaging in People With Gaucher MutationsCompletedNCT00302146
- Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher DiseaseCompletedNCT00244582
- OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher DiseaseCompletedNCT00041535Phase 2
- Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into Peripheral Blood Stem Cells for Autologous Transplantation in Patients With Type I Gaucher DiseaseCompletedNCT00004294Phase 1
- Phase II Study of Glucocerebrosidase in Patients With Gaucher DiseaseStatus unknownNCT00004293Phase 2
- Bone Response to Enzyme Replacement in Gaucher's DiseaseCompletedNCT00001416Phase 2
- PEG-Glucocerebrosidase for the Treatment of Gaucher DiseaseCompletedNCT00001410Phase 1
- Effects of Enzyme Replacement in Gaucher's DiseaseCompletedNCT00001289
- Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming CellsCompletedNCT00001234Phase 1